0001209191-17-041328.txt : 20170622 0001209191-17-041328.hdr.sgml : 20170622 20170622160428 ACCESSION NUMBER: 0001209191-17-041328 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170620 FILED AS OF DATE: 20170622 DATE AS OF CHANGE: 20170622 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: bluebird bio, Inc. CENTRAL INDEX KEY: 0001293971 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 60 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 339-499-9300 MAIL ADDRESS: STREET 1: 60 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Genetix Pharmaceuticals Inc DATE OF NAME CHANGE: 20040616 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LYNCH DANIEL CENTRAL INDEX KEY: 0001177082 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35966 FILM NUMBER: 17925116 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-06-20 0 0001293971 bluebird bio, Inc. BLUE 0001177082 LYNCH DANIEL C/O BLUEBIRD BIO, INC. 60 BINNEY STREET CAMBRIDGE MA 02142 1 0 0 0 Common Stock 2017-06-20 4 M 0 2500 2.0864 A 5300 D Common Stock 2017-06-20 4 S 0 2500 120.028 D 2800 D Stock Option (right to buy) 2.0864 2017-06-20 4 M 0 2500 0.00 D 2021-07-31 Common Stock 2500 2008 D This sales reported in the Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on December 14, 2016. The range of prices for the transaction reported on this line was $120.00 to $120.20. The average weighted price was $120.0280. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. This option vests over a four-year period in 48 equal monthly installments beginning on April 15, 2011 /s/ Jason F. Cole, Attorney-in-Fact 2017-06-22